36 Current evidence suggests a possible link to depressive or suicidal ideation specific to semaglutide 37, and a clearly higher incidence of gastrointestinal adverse events compared with liraglutide.38 Both remain FDA-approved and well-studied
For patients who take morning medications, have young children to get ready, or tend to eat breakfast immediately after waking, this routine requires real adjustment
It was approved by the FDA in 2017 for managing type 2 diabetes, and has since gained popularity due to its weight-loss effects
"This all appears to be a good news story," said Susan Jebb, a public health nutrition scientist at Oxford University and co-author of a new BMJ study
For individuals struggling with obesity, this powerful peptide reduces hunger and slows digestion, leading to weight loss
That finding deserves emphasis